台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953);;recombinant neisseria meningitidis group b nada protein (rp961c);;recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741);;outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 - 懸浮注射液 - recombinant neisseria meningitidis group b nhba fusion protein (rp287-953) (8008004010) mcg; recombinant neisseria meningitidis group b nada protein (rp961c) (8008004020) mcg; recombinant neisseria meningitidis group b fhbp fusion protein (rp936-741) (8008004030) mcg; outer membrane vesicles (omv) from neisseria meningitidis group b strain nz98/254 measured as amount of total protein containing the pora p1.4 (8008004040) mcg - meningococcus b, multicomponent vaccine - 適用於2個月以上兒童及成人之主動免疫接種，以預防b型奈瑟氏腦膜炎雙球菌所引起的侵入性腦膜炎雙球菌疾病。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487) - immunoglobulin human - 注射液劑 - 主成分 (active ingredients and amount per dose unit：) ; immunoglobulin human (8004000603) mg/ml - immunoglobulins, normal human, for extravascular adm. - 成人、兒童和青少年（0-18歲）之替代療法：(1) 原發性免疫不全症(primary immunodeficiency syndrome)（例如：先天性丙種免疫球蛋白缺乏症(congenital agammaglobulinemia)和丙種免疫球蛋白過低症(hypogammaglobulinemia)、常見變異性免疫不全症(common variable immunodeficiency)、嚴重複合型免疫不全症(severe combined immunodeficiency)及 wiskott-aldrich氏症候群）。(2) 慢性淋巴性白血病(chronic lymphocytic leukemia)引致低丙種免疫球蛋白血症及復發性細菌感染，且預防性抗生素治療無效或不適合接受(contra-indicated)預防性抗生素治療的病人。(3)多發性骨髓瘤(multiple myeloma)引致低丙種免疫球蛋白血症及復發性細菌感染的病人者。(4) 異體造血幹細胞移植前後引致丙種免疫球蛋白過低。成人，兒童和青少年的免疫調節療法（0-18歲）hizentra可作為慢性脫髓鞘多發性神經炎（cidp）病人的維持療法，於ivig治療穩定後使用。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

賽諾菲股份有限公司 台北市信義區松仁路3號7樓 (97168356) - glimepiride;;metformin hcl (eq to metformin hydrochloride) - 膜衣錠 - metformin hcl (eq to metformin hydrochloride) (6820400710) mg; glimepiride (6820601200) mg - metformin and sulfonylureas - 治療以glimepride或metformin單一藥物療法仍無法達到適當的血糖控制之第二型糖尿病患者，作為飲食和運動之外的輔助。不適合作第一線治療。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487) - factor ix - 注射劑 - factor ix (2012100700) 120iu (i - coagulation factor ix - 預防及治療b型血友病(先天性第九凝血因子缺乏症)患者之出血。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487) - human plasma fraction enriched in blood coagulation factor viii and having a factor viii c - 凍晶注射劑 - human plasma fraction enriched in blood coagulation factor viii and having a factor viii c (2012102500) i.u. - coagulation factor viii - 先天及後天缺乏第八凝血因子症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

永豐化學工業股份有限公司 新北市新莊區新樹路２９２號 (03155301) - water for injection - 注射劑 - water for injection (9604000900) 5ml - solvents and diluting agents, incl. irrigating solutions - 藥品溶劑

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣大塚製藥股份有限公司 台北市中山區復興北路378號11樓 (14001297) - l-leucine;;l-isoleucine;;l-valine;;l-lysine acetate;;l-threonine;;l-tryptophan;;l-methionine;;acetylcysteine;;l-phenylalanine;;l-tyrosine;;l-arginine;;l-histidine;;l-alanine;;l-proline;;l-serine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-aspartic acid;;l- glutamic acid;;potassium acetate;;sodium citrate hydrous;;nicotinamide;;folic acid;;riboflavin phosphate sodium;;ascorbic acid;;biotin;;vitamin a oil;;cholecalciferol ( eq to vit d3) ( eq to vitamin d3);;tocopherol acetate;;phytonadione;;glucose;;sodium chloride;;potassium acetate;;potassium phosphate ( eq to potassium phosphate dibasic);;calcium chloride hydrate;;magnesium sulfate hydrate;;zinc sulfate hydrate;;thiamine chloride hydrochloride;;pyridoxine hydrochloride;;cyanocobalamin (vit b12);;panthenol - 注射劑 - potassium acetate (4008000100) mg; sodium citrate hydrous (4008000870) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-aspartic acid (4020100402) mg; l- glutamic acid (4020100703) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; l-lysine acetate (4020101322) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; acetylcysteine (4800000100) mg; nicotinamide (8810000330) ug; folic acid (8811600100) ug; vitamin a oil (8804000105) iu; biotin (8810000100) ug; riboflavin phosphate sodium (8810200700) mg; ascorbic acid (8816000102) mg; cholecalciferol ( eq to vit d3) ( eq to vitamin d3) (8818000300) ug; tocopherol acetate (8820000200) mg; phytonadione (9200070100) mg; potassium acetate (4008000100) mg; calcium chloride hydrate (4012000380) mg; sodium chloride (4012002100) mg; glucose (4020000700) gm; magnesium sulfate hydrate (5612001520) mg; potassium phosphate ( eq to potassium phosphate dibasic) (5612001900) mg; panthenol (8416000700) ug; thiamine chloride hydrochloride (8810101030) ug; pyridoxine hydrochloride (8810600330) ug; cyanocobalamin (vit b12) (8811200300) ug; zinc sulfate hydrate (9200010630) ug - combinations - 無法經口或經腸道營養補給或營養補給不充分，而必須經由中央靜脈補給營養時的水分、電解質、熱量、氨基酸及維生素之補給。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣大塚製藥股份有限公司 台北市中山區復興北路378號11樓 (14001297) - l-leucine;;l-isoleucine;;l-valine;;l-lysine acetate;;l-threonine;;l-tryptophan;;l-methionine;;acetylcysteine;;l-phenylalanine;;l-tyrosine;;l-arginine;;l-histidine;;l-alanine;;l-proline;;l-serine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-aspartic acid;;l- glutamic acid;;potassium acetate;;sodium citrate hydrous;;nicotinamide;;folic acid;;riboflavin phosphate sodium;;ascorbic acid;;biotin;;vitamin a oil;;cholecalciferol ( eq to vit d3) ( eq to vitamin d3);;tocopherol acetate;;phytonadione;;glucose;;sodium chloride;;potassium acetate;;potassium phosphate ( eq to potassium phosphate dibasic);;calcium chloride hydrate;;magnesium sulfate hydrate;;zinc sulfate hydrate;;thiamine chloride hydrochloride;;pyridoxine hydrochloride;;cyanocobalamin (vit b12);;panthenol - 注射劑 - potassium acetate (4008000100) mg; sodium citrate hydrous (4008000870) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-aspartic acid (4020100402) mg; l- glutamic acid (4020100703) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; l-lysine acetate (4020101322) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; acetylcysteine (4800000100) mg; nicotinamide (8810000330) ug; folic acid (8811600100) ug; vitamin a oil (8804000105) iu; biotin (8810000100) ug; riboflavin phosphate sodium (8810200700) mg; ascorbic acid (8816000102) mg; cholecalciferol ( eq to vit d3) ( eq to vitamin d3) (8818000300) ug; tocopherol acetate (8820000200) mg; phytonadione (9200070100) mg; potassium acetate (4008000100) mg; calcium chloride hydrate (4012000380) mg; sodium chloride (4012002100) mg; glucose (4020000700) gm; magnesium sulfate hydrate (5612001520) mg; potassium phosphate ( eq to potassium phosphate dibasic) (5612001900) mg; panthenol (8416000700) ug; thiamine chloride hydrochloride (8810101030) ug; pyridoxine hydrochloride (8810600330) ug; cyanocobalamin (vit b12) (8811200300) ug; zinc sulfate hydrate (9200010630) ug - multivitamins, other combinations - 無法經口或經腸道營養補給或營養補給不充分，而必須經由中央靜脈補給營養時的水分、電解質、熱量、氨基酸及維生素之補給。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

永信藥品工業股份有限公司 台中市大甲區頂店里中山路一段1191號 (56065601) - pemetrexed disodium heptahydrate;;pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) (eq. to pemetrexed.....100mg)mg; pemetrexed disodium heptahydrate (1004002410) (eq. to pemetrexed.....500mg)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed (as pemetrexed disodium) (pemetrexed disodium is formed in situ from pemetrexed diacid)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。